Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain

By Jelena Martinovic
April 23, 10:24 AM
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) announced on Monday that it has submitted its letter of application for a Pre-IND meeting with the U.S. Food and Drug Administration (FDA, for its Liposome-Cannabidiol (LPT-CBD) injectable treatment of chronic pain. With the move, the company initiated the regulatory process with the FDA for the approval of its prolonged CBD release technology for human use.

CSE:INNO

Read More
2 minute read

Curaleaf Boosts International Presence With Another Cannabis Acquisition

By Jelena Martinovic
April 22, 10:18 AM
Cannabis giant Curaleaf Holdings is closing its previously announced acquisition of Northern Green Canada, a vertically integrated Canadian licensed cannabis producer focused primarily on expanding in the international market through its EU-GMP certification. Terms of the acquisition of NGC include an initial payment at closing of the company's subordinate voting shares valued at approximately $16 million, subject to a typical post-closing adjustment. In addition, an earnout may also be paid in 2025 based upon the 2024 performance of NGC's operations, up to 50% of which will be cash and the rest paid in additional subordinate voting shares.

CURLF

Read More
3 minute read

What’s The Net Worth Of These 4/20 Underdogs? Mid-Tier Cannabis Retailers & Cultivators Under The Spotlight

By Nicolas Jose Rodriguez
April 20, 2:27 PM
In the spotlight of Viridian Capital Advisors' latest Weekly Valuation Report are 16 Tier 2 and 3 U.S. cultivation and retail cannabis companies, each boasting market capitalizations between $10 million and $200 million.

FFNTF

Read More
3 minute read

4/20 Cannabis Retail Frenzy: Leading Brands Ready For Record Sales Surge – Who Will Lead?

By Nicolas Jose Rodriguez
April 20, 9:54 AM
This 4/20 cannabis retailers anticipate record-breaking sales fueled by last year's +130% spike and the fortunate alignment of this year's celebration falling on a Saturday.

AAWH

Read More
2 minute read

Canopy Growth’s Big Step Toward Entry Into US Cannabis Market As DEA Rescheduling Looms

By Jelena Martinovic
April 19, 1:28 PM
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) said that in connection with the creation of the company's non-voting and non-participating exchangeable shares, on Thursday, April 18, Greenstar Canada Investment Limited Partnership and CBG Holdings LLC, each a wholly-owned subsidiary of Constellation Brands Inc (NYSE: STZ) exchanged all 17,149,925 common shares in the capital of the company they collectively held for 17,149,925 exchangeable shares for no consideration. The CBG Group no longer holds any common shares of Canopy, as a result, the company said on Thursday. In connection with the termination of the investor rights agreement between CBG, Greenstar and Canopy Growth, the parties entered earlier and following the note exchange, Garth Hankinson, Judy Schmeling and James Sabia each provided notice to the company of his or her decision to resign from the board.

CGC